FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

2.

Clinical trial sees dramatic results using radiation to treat breast cancer

3.

Kate Middleton Announces Major Cancer Update

4.

Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests

5.

ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot